Clinical Trials Logo

KRAS NP_004976.2:p.G12D clinical trials

View clinical trials related to KRAS NP_004976.2:p.G12D.

Filter by:
  • Active, not recruiting  
  • Page 1

NCT ID: NCT03608631 Active, not recruiting - Clinical trials for Pancreatic Ductal Adenocarcinoma

iExosomes in Treating Participants With Metastatic Pancreas Cancer With KrasG12D Mutation

Start date: January 27, 2021
Phase: Phase 1
Study type: Interventional

This phase I trial studies the best dose and side effects of mesenchymal stromal cells-derived exosomes with KrasG12D siRNA (iExosomes) in treating participants with pancreatic cancer with KrasG12D mutation that has spread to other places in the body. iExosomes may work better at treating pancreatic cancer.